HMGB1 and lobular neoplasia: Notably, at the end of follow-up, immunosuppressive treatment only reduced HMGB1 expression in the serum and renal tissues of class IV LN patients, whereas HMGB1 levels in other patients with LN did not change significantly before and after treatment, possibly due to persistent chronic inflammation99.